©The Author(s) 2025.
World J Gastroenterol. Dec 14, 2025; 31(46): 114415
Published online Dec 14, 2025. doi: 10.3748/wjg.v31.i46.114415
Published online Dec 14, 2025. doi: 10.3748/wjg.v31.i46.114415
Table 1 Differentiation of human pluripotent stem cells into hepatic parenchymal and non-parenchymal cells
| Liver lineages | Stem cell types | Culture medium | Supplements | Days of induction | Biomarkers | Ref. |
| Hepatocyte-like cells | hiPSCs | RPMI/B27, KO-DMEM with KSR, IMDM | Activin A, Wnt3a, HGF, OSM, Dex, ITS premix | 12 days | AFP, albumin, CK18, HNF4, CYP3A4, CYP7A1 | Chen et al[76] |
| Hepatocyte-like cells | hiPSCs | Hepatocyte culture medium, IMDM, N2/B27 | Acitivin A, FGF4, BMP2, HGF, KGF, OSM, Dex | 21 days | AFP, albumin, CK8, CK18, CK19, PEPCK, HNF4α, HNF6, CEBPα, GATA4, HEX | Song et al[75] |
| Hepatocyte cells | GATA6- hiPSCs | StemFit04, IMDM/Ham’s F-12K, N2/B27 | L-ascorbic acid, Dex, 2-phosphate, basic fibroblast growth factor, 1-thioglycerol, HGF, nicotinamide, OSM | 18 days | Albumin, AAT, AFP, HNF4A, CYP3A4, CYP3A5 | Luo et al[126] |
| Hepatic cells | hESCs | DMEM/F12, KSR, 1640 medium | Activin A, aFGF, basic fibroblast growth factor, FGF4, HGF, BMP2, BMP4, Noggin, OSM, Dex, Su5402 | 18 days | PEPCK, CYP7A1, CYP3A4, CYP2B6 | Cai et al[74] |
| Hepatocytes | hPSCs | DEI medium A/B, CDM3 medium, CDM5 medium | A8301, FGF2, Acitivin A, BMP4, ATRA, AAP, TTNPB, OSM, insulin, forskolin, SB505124, 8-bromo-cAMP, DAPT, CHIR99021, AA2P, RO4929097, Dex | 18 days | Fumarylacetoacetate hydrolase, albumin, HGD | Ang et al[71] |
| Hepatic stellate cells | hiPSCs | Liver differentiation medium | BMP4, FGF1, FGF3, retinol, palmitic acid | 12 days | PDGFRβ, PCHD7, COL1α1 | Vallverdú et al[2] |
| Hepatic stellate cells | hPSCs | DMEM low glucose | BMP4, FGF1, FGF3, retinol, palmitic acid, ITS, Dex | 12 days | DES, P75NTR, ALCAM, ACTA2, COL1α1, LRAT, RELN, PCDH7, PDGFRβ | Coll et al[91] |
| Hepatic stellate cells | hESCs | DMEM/F-12, B27, FBS | Activin A, CHIR99021, BMP4, FGF1, FGF3, Y-27632, palmitic acid, retinol | 12 days | PDGFRβ, NCAM1, ALCAM, LRAT, ACTA2, vimentin | Wilhelmsen et al[92] |
| LSECs | hPSCs | EBM-2 medium, IMDM | BMP4, basic fibroblast growth factor, VEGF-A, CHIR99021, cAMP, GSI, SB431542, ITS-X, ascorbic acid, transferrin | 22 days | CD34, PECAM1, VWF, LYVE1, CD14, FCGR2B, CD36, CD54, STAB1, FVIII, STAB2, CLEC1B | Gage et al[97] |
| LSECs | hPSCs | IMDM, DMEM-F12, StemPro34, FCS | BMP4, Activin A, ascorbic acid, basic fibroblast growth factor, L-685-458, ITS-X, VEGF-A, CHIR99021, transferrin | 21 days | FCGR2B, LYVE1, STAB2, F8, CD14, MRC1, CD36, RAMP3, CD32B, FVIII | Gage et al[96] |
| LSECs | Mouse ESCs | IMEM, EGM2-MV, FBS | Adrenomedullin, SB431542, β-ME, VEGF-A, ITS | 20 days | F8, Fcgr2b, Mrc1 | Arai et al[100] |
| Cholangiocytes | hPSCs | RPMI 1640 medium, low glucose DMEM, B27, DMEM/F12, a-MEM | MTG, Acitivin A, CHIR99021, ascorbic acid, basic fibroblast growth factor, BMP4, HGF, EGF, OSM, Dex, RA, Noggin, Y-27632, forskolin | 49 days | Albumin, AFP, CFTR, TRPV4, PKD1, PKD2 | Ogawa et al[101] |
| Cholangiocytes | hiPSCs | RPMI, B27, William’s E medium | Acitivin A, FGF2, FGF10, BMP4, Ly294002, SB431542, RA, EGF | 26 days | SSTR2, ALP, KRT7, SOX9 | Sampaziotis et al[102] |
| Kupffer cells | hiPSCs | X-VIVO 15 media, PHCM, advanced DMEM | M-CSF, IL-3, streptomycin | 4-5 weeks | CD163, CD200R, CD86, IL-6, CSF1, HLA-DRB1, IL-1β | Tasnim et al[106] |
| Kupffer cells | hESCs; cord blood | DMEM/F12, KSR, IMDM, RPMI 1640 | BMP4, basic fibroblast growth factor, Activin A, IL-3, IL-7, M-CSF, TPO, SCF | 9-17 days (cord blood); > 90 days (hESCs) | MARCO, CD5 L, TIMD4, VCAM1, CPVL, VSIG4, FOLR2, CD163 | Kent et al[99] |
- Citation: Wang YX, Ren YN, Zhang SS, Sun S, Xu MY, Wei T, Zhang LS. Application of stem cells in the precise diagnosis and treatment of liver diseases. World J Gastroenterol 2025; 31(46): 114415
- URL: https://www.wjgnet.com/1007-9327/full/v31/i46/114415.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i46.114415